About: Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 02 April 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu n'abril de 2020 (ast) scientific article published on 02 April 2020 (en) наукова стаття, опублікована 2 квітня 2020 (uk)
publication date	wds:Q91578226-CAC4D84D-D636-40F3-BA1A-A39F1350509C
publication date	2020-04-02 00:00:00Z (xsd:dateTime)
cites work	wds:Q91578226-13ADCA10-263B-40FB-B9D4-DB10D2A0EC04 wds:Q91578226-1BDE1B1A-085A-4D4E-B9F6-1A091A6CC349 wds:Q91578226-2654386A-5386-4037-807C-D18AF84C79CA wds:Q91578226-56A550B9-5D98-4398-9001-8CE197E8E09E wds:Q91578226-70362C85-22E0-4A49-959D-448196AFF734 wds:Q91578226-8E56528B-9A33-478E-B10D-ED44D0AE4FB4 wds:Q91578226-944311CE-73FB-4081-8797-64DD3D910883 wds:Q91578226-99AC3C61-7E46-4017-9978-43975DDB773E wds:Q91578226-9B711060-F92F-4D97-B176-52F4EB612E57 wds:Q91578226-CA2862CB-BF1F-4840-8CEC-D9F5E9AFF15D wds:Q91578226-D23FBE3B-7B74-4B29-B034-F056356EDD4C wds:Q91578226-E87AE71C-55A5-4E4B-9FE8-D2E3496B2339 wds:Q91578226-EB3DC343-E787-401D-A260-8D8313E6B6EA wds:Q91578226-EE3F2EC0-B430-4D94-A1EC-86190B61538C wds:Q91578226-F1084C4E-BD48-4FD3-AF2B-81A05D785AF3
cites work	The spike protein of SARS-CoV--a target for vaccine and therapeutic development Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge MERS-CoV spike protein: a key target for antivirals Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. A pneumonia outbreak associated with a new coronavirus of probable bat origin An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
author name string	wds:Q91578226-7D7266E6-0E2F-4F68-BB5E-976C75324C3F wds:Q91578226-A6B7DF42-0A5B-404E-BC27-C023845EB3C4 wds:Q91578226-EF92A0FB-7342-40F5-999B-769967FFEE42
author name string	Lanying Du Shibo Jiang Christopher Hillyer
rdfs:label	Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (en) Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (nl)
skos:prefLabel	Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (en) Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (nl)
name	Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (en) Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (nl)
title	wds:Q91578226-4EC39872-5A7F-424C-93CD-2D952CE1CD5A
title	Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (en)
instance of	wds:Q91578226-16D773AC-5187-4527-B5BE-099E2EBB94F0 wds:Q91578226-1e9d4a1b-554f-4d32-9c89-f555d85aef96
instance of	review article scholarly article
main subject	wds:Q91578226-A7F0A316-BA6F-4227-9202-7582D085B64B wds:Q91578226-A899C0E5-63AB-400C-B8B4-B23CFA5D78E2
main subject	SARS-CoV-2 COVID-19 mortality
PubMed ID	wds:Q91578226-A87D29F3-794C-432F-BE6D-06D8CB2C621A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32249063
PubMed ID	32249063
published in	wds:Q91578226-77C826F6-7B88-4994-AF18-A549B45F62FC
published in	Trends in Immunology
DOI	wds:Q91578226-582F2B95-E013-48B8-8F31-86A49C6F6219
DOI	http://dx.doi.org/10.1016/J.IT.2020.03.007
DOI	10.1016/J.IT.2020.03.007
Dimensions Publication ID	wds:Q91578226-6CD398CA-F865-4512-885C-77309DE3DC6C
Dimensions Publication ID	1126048459
PMCID	wds:Q91578226-03280319-D976-41F9-876B-2711CAA5AD66
PMCID	7129017
COVIDWHO ID	wds:Q91578226-BFDD8EB7-D1D2-4728-B94E-33901B0EB7DB
COVIDWHO ID	covidwho-26756
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91578226
is cites work of	The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection Convergent antibody responses to SARS-CoV-2 in convalescent individuals Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients Immunological considerations for COVID-19 vaccine strategies Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19 Potently neutralizing and protective human antibodies against SARS-CoV-2 Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology Glycosylation is a key in SARS-CoV-2 infection Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2 Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software